Related Experiment Videos
Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function
Buddhadeb Dawn1, Yiru Guo, Arash Rezazadeh
1Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40292, USA.
Circulation Research
|March 25, 2006
Summary
Cytokine therapy using granulocyte colony-stimulating factor (G-CSF) plus Flt-3 ligand (FL) or stem cell factor (SCF) improves cardiac function after myocardial infarction by promoting tissue regeneration. G-CSF alone showed less effectiveness.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Immunology
Background:
- Myocardial infarction (MI) leads to adverse left ventricular (LV) remodeling and impaired cardiac function.
- Cytokine therapy is being explored for its potential to promote cardiac repair post-MI.
- Understanding the comparative efficacy of different cytokine combinations is crucial for therapeutic development.
Purpose of the Study:
- To compare the efficacy of three cytokine regimens (G-CSF+FL, G-CSF+SCF, G-CSF alone) in regenerating cardiac tissue and improving LV function after reperfused MI.
- To investigate the mechanisms underlying cytokine-induced cardiac regeneration, including bone marrow-derived cell mobilization and differentiation.
Main Methods:
- Wild-type and chimeric mice underwent a 30-minute coronary occlusion followed by reperfusion.
- Mice received vehicle, G-CSF+FL, G-CSF+SCF, or G-CSF alone starting 4 hours post-reperfusion.
- Cardiac function and structure were assessed echocardiographically and morphometrically 5 weeks later. Chimeric mice allowed tracking of bone marrow-derived cells.
Main Results:
- G-CSF+FL and G-CSF+SCF treatments significantly improved LV function and reduced LV dimensions compared to vehicle.
- G-CSF alone showed less improvement in LV function but reduced LV dimensions.
- Chimeric mice treated with G-CSF+FL or G-CSF+SCF exhibited increased cardiac regeneration, evidenced by numerous EGFP-positive cardiomyocytes, capillaries, and arterioles in the infarct zone. G-CSF+FL therapy also mobilized bone marrow cells with enhanced homing markers (CD62L, CD11a).
Conclusions:
- Post-infarct cytokine therapy with G-CSF+FL or G-CSF+SCF effectively limits adverse LV remodeling and improves cardiac performance.
- These regimens promote cardiac regeneration, likely through the recruitment and differentiation of bone marrow-derived cells.
- G-CSF+FL and G-CSF+SCF are more effective than G-CSF alone in promoting cardiac repair after myocardial infarction.